We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Industry Skeptical of FDA's Proposed User Fee Hikes
Drug Industry Skeptical of FDA's Proposed User Fee Hikes
December 14, 2005
Drug industry representatives are expressing reservations about the FDA’s proposed plan to raise user fees to pay for certain activities that are not directly related to product application review.